Laurel Wealth Advisors (California)’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $412K | Buy |
3,138
+356
| +13% | +$46.7K | 0.04% | 408 |
|
|
2022
Q3 | $325K | Sell |
2,782
-683
| -20% | -$79.8K | 0.03% | 463 |
|
|
2022
Q2 | $408K | Buy |
3,465
+446
| +15% | +$52.5K | 0.04% | 409 |
|
|
2022
Q1 | $393K | Buy |
3,019
+557
| +23% | +$72.5K | 0.03% | 496 |
|
|
2021
Q4 | $376K | Buy |
2,462
+799
| +48% | +$122K | 0.03% | 553 |
|
|
2021
Q3 | $269K | Sell |
1,663
-635
| -28% | -$103K | 0.05% | 366 |
|
|
2021
Q2 | $376K | Sell |
2,298
-22
| -0.9% | -$3.6K | 0.05% | 345 |
|
|
2021
Q1 | $349K | Sell |
2,320
-214
| -8% | -$32.2K | 0.05% | 324 |
|
|
2020
Q4 | $384K | Sell |
2,534
-122
| -5% | -$18.5K | 0.06% | 296 |
|
|
2020
Q3 | $360K | Buy |
2,656
+14
| +0.5% | +$1.9K | 0.06% | 275 |
|
|
2020
Q2 | $361K | Buy |
2,642
+387
| +17% | +$52.9K | 0.07% | 266 |
|
|
2020
Q1 | $243K | Buy |
2,255
+269
| +14% | +$29K | 0.06% | 311 |
|
|
2019
Q4 | $240K | Buy |
+1,986
| New | +$240K | 0.04% | 393 |
|
|
2016
Q2 | – | Sell |
-300
| Closed | -$26K | – | 271 |
|
|
2016
Q1 | $26K | Buy |
+300
| New | +$26K | 0.01% | 260 |
|